Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib, Temozolomide, and Radiation Therapy in Glioblastoma Multiforme
NCT00039494Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2002
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in glioblastoma multiforme (GBM), Gliosarcoma (GS), astrocytoma, sponsored by National Cancer Institute. Started Dec 2002; status: completed.
02
Drugs
erlotinib
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)astrocytoma
Beyond the preview
Go deeper on NCT00039494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039494.